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Abstract.  Schwann cells in culture divide in response 
to defined mitogens such as PDGF and glial growth 
factor (GGF), but proliferation is greatly enhanced if 
agents such as forskolin, which increases Schwann cell 
intracellular cAMP, are added at the same time as 
PDGF or GGF (Davis, J.  B., and P.  Stroobant.  1990. 
J.  Cell Biol.  110:1353-1360).  The effect of forskolin is 
probably due to an increase in numbers of PDGF 
receptors (Weinmaster, G., and G.  Lemke.  1990. 
EMBO (Eur. Mol.  Biol.  Organ.)J.  9:915-920. 
Neuropeptides and/$-adrenergic agonists have been 
reported to have no effect on potentiating the mito- 
genic response of either PDGF or GGE We show that 
the neuropeptide calcitonin gene-related peptide 
(CGRP) increases Schwann cell cAMP levels, but the 
cells rapidly desensitize. We therefore stimulated the 
cells in pulsatile fashion to partly overcome the effects 
of desensitization and show that CGRP can synergize 
with PDGF to stimulate Schwann cell proliferation, 
and that CGRP is as effective as forskolin in the pul- 
satile regime. 
CGRP is a good substrate for the neutral endopepti- 
dase 24.11.  Schwann cells in vivo have this protease 
on their surface, so the action of CGRP could be ter- 
minated by this enzyme and desensitization prevented. 
We therefore suggest that CGRP may play an impor- 
tant role in stimulating Schwann cell proliferation by 
regulating the response of mitogenic factors such as 
PDGE 
T  nEaE are two circumstances in which Schwann ceils, 
the glial cells of peripheral nerves, proliferate: during 
development and after nerve injury. During develop- 
ment, they proliferate as they migrate out along growing 
axons (Eccleston,  1992).  After nerve injury, they undergo 
two waves of proliferation: one occurs acutely, adjacent to 
the injury site, whereas the second occurs over a prolonged 
period as the nerve undergoes Wallerian degeneration and 
regeneration and extends distally from the injury site (Faw- 
cett and Keynes, 1990).  Although it is still not clear how 
Schwann cell division is controlled in vivo, there has been 
considerable effort to identify the mitogens that regulate the 
proliferation of rat sciatic nerve Schwann cells in culture. 
PDGF, FGF-1 and FGF-2, TGF-/~, and glial growth factor 
(GGF) m  have all been shown to promote the proliferation of 
these ceils. In addition, Schwann cells in culture respond to 
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axons and  axonal membrane  fractions (Eccleston,  1992; 
Rather et al., 1988). A striking feature of the response of cul- 
tured Schwann cells to each of the defined growth factors, 
however, is that the response is greatly potentiated if the in- 
tracellular  level  of  cAMP  is  raised  by  treatment  with 
dibutyryl cAME  cholera toxin,  or  forskolin (Raft et al., 
1978a,b;  Ridley et al.,  1989;  Davis and Stroobant,  1990; 
Weinmaster and Lemke, 1990; Chen et al., 1991; Stewart et 
al.,  1991; Goodearl et al.,  1993; Marchionni et al., 1993). 
With the exception of GGF (Goodearl et al., 1993), there is 
significant expansion of Schwann cell numbers in response 
to each of these mitogens only if cAMP levels are also in- 
creased with agents such as forskolin. The growth factors 
themselves do not signal via cAMP, but increases in cAMP 
increase the levels of mRNAs encoding growth factor recep- 
tors in Schwann cells (Cohen et al., 1992; Weinmaster and 
Lemke, 1990),  which may account, in part at least, for the 
synergy. 
It is not known if cAMP signaling pathways play an impor- 
tant part in the control of Schwann cell proliferation in vivo 
and if they do, what endogenous signals are responsible for 
increasing cAMP in these cells. Potential candidates, such as 
catecholamines and  neuropeptides,  have previously been 
reported not to promote Schwann cell proliferation in culture 
(Raft et al.,  1978a;  Davis and Stroobant,  1990;  Stewart et 
al., 1991). In this study, we have reinvestigated the action of 
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cyclase in various cell types, that are made by motor neu- 
rons,  sensory neurons, or both, and whose synthesis has 
been shown to increase after peripheral nerve injury. These 
include calcitonin gene-related peptide (CGRP), vasoactive 
intestinal  peptide  (VIP)  and  peptide  histidine-isoleucine 
(PHI). CGRP is normally made by both sensory and motor 
neurons, and its synthesis is increased in motor neurons after 
nerve injury (Arvidsson et al., 1990; Dumoulin et al., 1990; 
Noguchi et al., 1990). VIP and PHI are normally expressed 
in only a small subset of sensory neurons in the dorsal root 
ganglion, but many sensory neurons express both VIP and 
PHI after injury (McGregor et al., 1984; Shehab and Atldn- 
son, 1986; Nielsch and Keen, 1989). We also tested galanin 
and neuropeptide Y,  which do not usually act via cAMP 
pathways but increase in sensory neurons after injury (Villar 
et al.,  1989; Kashiba et al.,  1992;  Wakisaka et al.,  1992; 
Hokfelt et al., 1994). The increased synthesis of these pep- 
tides after nerve injury suggests that they may play a special 
part  in nerve regeneration, especially as the  synthesis of 
other  neuropeptides  and  transmitter-related  enzymes de- 
creases after nerve injury and during nerve regeneration (for 
review  see  Hokfelt et al.,  1994).  We also compared the 
effects of the neuropeptides with the ~-adrenergic agonist 
isoproterenol,  which  classically  stimulates  adenylate cy- 
clase, although the enzymes that synthesize adrenergic trans- 
mitters  decrease  after  nerve  injury  (Cheah  and  Geffen, 
1973). 
We show that, although CGRP is a potent stimulator ofad- 
enylate cyclase activity in Schwarm cells, the resulting in- 
crease in Schwann cell intracellular cAMP is transient, as the 
cells  rapidly desensitize.  Consequently, continuous treat- 
ment with CGRP does not promote Schwann cell prolifera- 
tion in the presence of PDGE By contrast, pulsatile treat- 
ment with CGRP is as potent at promoting Schwann cell 
proliferation in the presence of PDGF as is pulsatile treat- 
ment with forskolin and PDGF.  These results suggest that 
CGRP may play an important role in stimulating Schwann 
cell proliferation in development, injury, or both. In addi- 
tion,  we  show  that  sciatic  nerve  fibroblasts  respond  to 
CGRP, VIP and PHI,  suggesting that these neuropeptides 
may also regulate fibroblast behavior in nerve regeneration. 
Materials and Methods 
Animals and Materials 
Newborn rats were obtained from the breeding colony of the University 
College London Animal Facility.  Recombinant human PDGF-BB was pur- 
chased from R&D Systems, Inc. (Minneapolis, MN). The neuropeptides 
CGRP, VIP, PHI, galanin, and nenropeptide Y, as well as forskolin, isopro- 
terenol,  3-isobutyl-l-methyl-xanthine (IBMX),  5-bromo-2'-deoxyuridine 
(BrdU),  poly-I>-lysine,  laminin  (Sigma  Chemical  Co.,  Poole,  UK; 
catalogue-L2020),  trypsin (type III),  collagenase (Sigma Chemical Co.; 
catalogue-C9263), BSA (fraction V and crystalline fraction V), and DNase 
were purchased from Sigma Chemical Co. (St.  Louis, MO). FCS, Earrs 
balanced salt solution (EBSS), L-15, Ham's F12, and DME with glutamax-I 
media were purchased from GIBCO BRL (Paisley,  Scotland). Tissue cul- 
ture plastics were from Falcon Labware (Oxnard, CA). The monoclonal 
anti-Thy  1.1 (OX7) and anti-BrdU hybridomas were gifts from A. Williams 
(Oxford University, Oxford,  UK),  and  D.  Mason (Oxford University), 
respectively. Purified mAb OX42 was from Sera-Lab Ltd. (Sussex, UK), 
and anti-mouse Ig antibodies as well as conjugates were purchased from 
Dako-Patts (Olostrup, Denmark). The dual range 12SI-cAMP radioimmu- 
noassay kit was from Amersham International  (Amersham, UK). 
Purification of  ~'broblasts and Schwann Cells by 
Sequential lmmunopanning 
Cell Preparation. Sciatic nerves were dissected from 10-20 rats taken on 
postnatal days 5-7, finely chopped with a scalpel and forceps, then incubated 
at 37°C for 35 rain in EBSS containing 0.025% trypsin, 0.1% collagenase, 
and 0.004% DNase; enzymes were inactivated by addition of 10% FCS and 
the suspension  centrifuged. The cell pellet was resuspended in L-15 medium 
with 0.1% BSA, further dissociated by trituration with a  1-ml Pipetteman 
(Anachem, Luton, UK), and then filtered through nylon mesh (20-/~m pore 
size) to obtain a single-cell suspension. 
Preparation of Panning Dishes. The method is a modification of that 
used by Barres et al. (1992).  Panning dishes were prepared by incubating 
100-mm Petri dishes overnight at 4°C with  I0 ml of 0.2  M  carbonate- 
bicarbonate buffer,  pH 9.5, containing 50/zg of rabbit anti-mouse Ig. Fol- 
lowing aspiration of buffer,  the dishes were washed three times with PBS 
before coating with cell type-specific mAb for at least I h in PISS with 0.2 % 
BSA at room temperature; the plates were washed three times before the 
cell suspensions were added. 
lmmunopanning Procedure. Single-cell suspensions were applied se- 
quentially to panning dishes coated with either OX42 (1/~g/ml) to remove 
macrophages and other while blood cells or OX7 (hybridoma supernatant, 
diluted  1:20)  to remove Thy-I  + fibroblasts. The cell suspension was in- 
cubated  with  each  dish for  30  min  at  room  temperature and  agitated 
vigorously at  15 and 30 rain to prevent nonspecific binding; the medium 
containing nonadherent cells was then transferred to the next dish. The ad- 
herence of  cells to each type of  panning dish was monitored microscopically 
until no further adhesion of  cells was seen, and the depleted cell suspension 
was then transferred to the next type of panning dish. 
To prepare pure nerve fibroblasts, the cell suspension was incubated se- 
quentially on one or two OX42 dishes, then on one or two OX7 dishes. The 
fibroblasts that stuck to OX7 dishes were washed at least six times under 
microscopic control until all loosely attached cells were removed. They 
were then incubated overnight in a CO: incubator at 37°C in DME with 
glutamax-1 and Ham's F12 media mixed 1:1 and supplemented with penicil- 
lin (100 U/ml) and streptomycin (100 tzg/rnl) (DME/F12) plus 10% FCS. 
The following day the fibroblasts were harvested by trypsinization (0.125 % 
trypsin in EBSS for 10 rain at 37°C); the enzyme was inactivated with 10% 
FCS, and the cells were squirted offthe dish with a 1-ml Pipetteman. After 
centrifugation, the fibroblasts were resuspended in DME/FI2  with  10% 
FCS and were plated into 24-well tissue culture plates, either with or with- 
out glass coverslips. 
To prepare purified Schwann cells, the cells previously incubated with 
OX42  and OX7 dishes were incubated with further OX7 dishes to max- 
imally remove Thy-1  + fibroblasts; in general, a  cell suspension from 20 
7-d-old rats required at least two OX42 dishes and four or five OX7 dishes 
to deplete the Sehwann cell preparation of  other cell types. After centrifnga- 
tion, the cell pellet was washed several times with DME/FI2 containing 
0.5% crystalline BSA, resuspended in defined tissue culture medium, and 
plated into 24-well tissue culture plates, either with or without glass cover- 
slips. 
Schwann Cell Cultures 
Purified Schwann cells were plated into 24-well plates either with or without 
coverslips. Each well was previously coated with poly-D-lysine (1 mg/ml in 
water) washed three times and air dried, and then incubated with laminin 
(10/zg/ml in DME/F12). In the case of coverslips, the laminin was confined 
to a 50-/zl drop, whereas wells without coverslips were completely covered 
by the laminin. The cells were plated at 50,000-100,000 cells per well, ei- 
ther in 500-/zl (no coverslips) or 50-#1 drops (on coverslips); in the latter 
case the wells were topped up to 500/~l after the cells attached to the cover- 
slips. The growth medium for Schwann cells was DME/F12 (see above) 
with defined additives modified from Bottenstein and Sato 0979) as fol- 
lows: 100/~g/ml transferrin, 16/~g/ml putrescine, 5/zg/ml insulin, 50 ng/ml 
thyroxine, 50 ng/ml triiodothyronine, 39 ng/ml sodium selenite, 100 ~g/ml 
crystallized BSA. After 24 h the cultures were washed three times with me- 
dia to remove any debris from the wells. Schwann cells were usually grown 
for 2-3 d  and washed twice with defined medium before starting an ex- 
periment. 
Fibroblast Cultures 
Fibroblasts were plated at a density of 5,000-10,000 per well into Primaria 
grade 24-well plates without coverslips or into 24-well plates with poly-D- 
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The cells were grown for 2-3 d and washed with DME/FI2 twice before 
starting an experiment. 
Purity and Yield of Schwann Cells and Fibroblasts 
Freshly dissociated cells, as well as cells prepared by immunopanning, were 
allowed to  settle onto coverslips for  1 h  and were then fixed with 4% 
paraformaldehyde; cells were also fixed at 24 h or 4  d after plating. The 
ceils were stained with either OX42 or OX7 mAbs followed by biotinylated 
anti-mouse Ig and then streptavidin-tluorescein. Some coverslips were la- 
beled with a rabbit anti-S100 antiserum followed by hiotinylated anti-rabbit 
Ig or OX7 followed by biotinylated anti-mouse Ig and streptavidin-horse 
radish peroxidase, and the antibody labeling was visualized by reaction with 
diaminobenzidine; the nuclei were then stained with hematoxylin. 
1 or 24  h  after dissociation, mixed P7  sciatic nerve cells contained 
,M.5%  OX42  ÷  cells  (macrophages),  ,,o13% OX7  +  cells  (Thy-1  +  fibro- 
blasts), and '~85 % SI00  ÷ cells (Schwann cells). After negative panning on 
OX42 and OX7 dishes, the proportion of S100 + Schwann cells was 98%, 
whereas the remaining cells were OX7  + and had the morphology of fibro- 
blasts after 24 h in culture; there were no OX42" cells after panning. After 
4  d  in serum-free medium without growth factors, almost all the Thy-I + 
cells were pyknotic. Fibroblasts prepared by positive panning on OX7 plates 
were 99.9% Thy-1  + at the time of plating, and these cells survived well in 
serum-comaining medium as well as in serum-free medium for several days 
at the density plated. After panning, the yield of S100 + Schwann cells and 
Thy-1 + fibroblasts from 20 P7 animals was 'x,15  x  106 and 0.6  ×  106, 
respectively. 
cAMP  Assays 
To ensure an accurate time of exposure to test materials in all wells, the ex- 
periment was terminated by inverting the culture plate on blotting paper and 
then lysing the cells in each well by inverting the test plate over a similar 
plate containing ice-cold 65 % ethanol in each well and then inverting the 
two plates together, cAMP was then extracted for at least 2 h  at  -20°C, 
and the ethanol-containing  cAMP was transferred to borosilicate glass tubes 
and evaporated by vacuum using a Speed Vac (model SC100;  Savant,  Far- 
mingdale,  NY).  The  cAMP-containing pellet was  resuspended in assay 
buffer, and the cAMP content of each sample, was measured in duplicate 
using the nonacetylation method of the cAMP RIA kit as directed, except 
that all components of the RIA were diluted 1:3 to increase the number of 
samples per kit (this did not affect the accuracy of the assay). Radioactivity 
in the antibody pellet was determined in a gamma counter (NE1600; Nu- 
clear Enterprises, Edinburgh, UK). 
BrdU Labeling and Immunofluorescence 
DNA synthesis by purified Schwann cells was detected by addition of BrdU 
at a concentration of 10 #M for the final 24-30 h of culture. Living cells 
were incubated with OX7 (supernatant diluted 1:1 in L15 with 5% calf se- 
rum and 0.1%  sodium azide) followed by Texas red goat anti-mouse IgG 
(1:100) to label the fibroblasts. They were then fixed in 4% paraformalde- 
hyde for 1 rain and treated with 2 N HCI for 10 min to denature the DNA 
and with 100 mM sodium borate (pH 8.5) for 10 min. The cells were then 
incubated sequentially with anti-BrdU antibody (supernatant diluted l:l in 
PBS containing 100 mM lysine, 5%  calf serum, Triton X-100,  and 0.1% 
sodium azide), biotinylated sheep anti-mouse Ig, and streptavidin fluores- 
cein (Amersham International, Amersham, UK; both diluted 1:100 in the 
same solution). Coverslips were mounted in Citifluor (City University, Lon- 
don, UK), sealed with nail polish, and examined with a fluorescence micro- 
scope (Zeiss). The Thy-1 surface labeling (red and green) was easily distin- 
guished from the nuclear BrdU labeling (green). 
Results 
Accumulation of  cAMP by Schwann Cells 
and Fibroblasts 
We tested the ability of various neuropeptides and isoproter- 
enol  to  stimulate  the  accumulation  of  cAMP  in  purified 
Schwann cells or fibroblasts that were in culture for either 
3 or 8 d. As shown in Fig.  1, both CGRP and isoproterenol 
increased intracellular cAMP in Schwann cells at both ages; 
the response to isoproterenol was more pronounced in 8-d 
cells, whereas the basal levels of cAMP and the response to 
CGRP were similar in 3 and 8-d cells. The magnitude of the 
CGRP response depended on the culture conditions, as cells 
plated at high density gave a larger increase in cAMP (ap- 
proximately eightfold) than the same number of cells plated 
over a  larger area  (approximately threefold), even though 
basal levels were similar. VIE PHI, galanin, and neuropep- 
tide Y had little effect. 
As shown in Fig. 2, isoproterenol also increased cAMP in 
purified sciatic nerve fibroblasts, and in the presence of the 
phosphodiesterase inhibitor IBMX,  CGRP,  VIE  and PHI 
did as well, but the effects of VIP and PHI were only seen 
in the older cultures.  Galanin and neuropeptide Y  had no 
effect. As shown in Fig. 3, a  and b, the CGRP-induced re- 
sponse was maximal at 5  x  10  -g M  in both Schwann cells 
and  fibroblasts,  whereas  the  isoproterenol  response  was 
maximal at 10  -~ M (not shown). The VIP-induced response 
in fibroblasts was maximal at 5  x  10  -7 M  (Fig. 3 b). 
Desensitization of  Schwann Cell Response to CGRP 
and Isoproterenol 
As shown in Fig. 4 a, the increase in cAMP in Schwann cells 
Figure 1. Intracellular levels of cAMP in Schwann cells in response 
to 10  -~ M  isoproterenol (ISOP) or 5  x  10  -s M  neuropcptides. Af- 
ter immunopanning, 50000 cells were plated in defined medium ei- 
ther over the entire well (sparse, stippled bars) or confined to the 
area of a 50-#1 drop (dense, hatched bars).  After either 3  d  (light 
hatched or stippled bars) or 8 d  (dark hatched or stippled bars)  in 
culture,  drugs  were  added  for  5  rain;  cells  were  extracted  and 
cAMP measured  as  described.  In this  and  the following experi- 
ments, 0.1%  crystalline BSA was included in all drug solutions to 
prevent neuropeptides from sticking to the tissue culture plastic. 
The data presented in this and Figs. 2-6 are means +SD for tripli- 
cate wells. All experiments are typical of results obtained in at least 
three different platings. [] 3d SC, sparse; •  3d SC, dense; 1  8d SC, 
sparse; •  8d SC,  dense. 
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Figure 2.  Intracellular levels of cAMP in sciatic nerve fibroblasts 
in response to either 10  -6 M isoproterenol (ISOP) or 5  x  10  -8 M 
neuropeptides.  After immunopanning,  5,000  cells were plated in 
10%  FCS and  allowed to divide in culture  for either 2  d  (light 
hatched bars) or 7 d (dark hatched bars).  The cells were washed 
and  incubated  in defined DME/F12 for 4  h  with 200/*M IBMX 
added for 2 h.  The cells were then stimulated for 2 min with the 
drugs in the presence of IBMX; cells were extracted, and cAMP 
was measured as described.  ~  2d,  +IBMX; []  7d,  +IBMX. 
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Figure  3.  (a)  CGRP  dose- 
response curve for cAMP ac- 
cumulation in Schwann cells. 
Cells were plated at high den- 
sity  (50,000  cells  per  50-/,1 
drop)  and  grown  in  defined 
medium  for 4  d.  Cells were 
washed,  and 200  /*M  IBMX 
was added to some wells; after 
2  h  various  doses  of CGRP 
were added  for 5  min either 
with (solid circles) or without 
(open  circles)  IBMX.  (b) 
CGRP and VIP dose-response 
curves for cAMP accumulation 
in  sciatic  nerve  fibroblasts. 
Cells were plated at 5,000 cells 
per well and allowed to divide 
in culture with  10%  FCS for 
3 d. After washing with DME/ 
F12,  200  /*M  IBMX  was 
added for 2 h; various doses of 
either CGRP (circles) or VIP 
(squares) were then added for 
2 min and the cells extracted. 
induced by a maximal dose of CGRP was eightfold higher 
than basal levels after 5 rnln without IBMX (ll-fold higher 
with IBMX), but declined rapidly, even in the presence of 
IBMX, so that it was only twofold higher than basal levels 
after 1 h. The attenuation of the response to CGRP in fibro- 
blasts was even more rapid (Fig. 4 b). The attenuation of the 
cAMP response was not due to degradation or inactivation 
of the peptide because, when culture medium from Schwann 
cells incubated with CGRP for 3 h was transferred to fresh 
cultures, a comparable stimulation of cAMP was seen after 
a further 5 min, just as with fresh CGRP. Moreover, adding 
fresh CGRP to the Schwann cells treated with CGRP for 3 h 
failed to increase cAMP in the cells after 5 min (Fig.  5). 
The response to isoproterenol also declined with time in 
similar fashion to the CGRP response. 
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Figure 4. (a) Time course for cAMP accumulation in response to 
CGRP in Schwann cells plated at high density and grown for 4  d 
in defined medium.  CGRP (5  ×  10  -s M),  either with (solid cir- 
cles) or without (open cicles) IBMX, was then added for various 
times in decreasing order and  the incubation terminated  at zero 
time.  For each time point with IBMX,  the drug  (200  #M)  was 
added for a total of 2 h.  (b) Time course for cAMP accumulation 
in response to CGRP in sciatic nerve fibroblasts plated at 5,000 
cells per well and grown for 3 d in 10% FCS. After washing, 200 
/*M IBMX was added to all wells for 2  h;  CGRP (5  x  10  -s M) 
was then added for various times in decreasing order and the incu- 
bation terminated at zero time. 
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CGRP and Isoproterenol 
To study the mitogenic effect of CGRP and isoproterenol on 
Schwann cells, we needed to overcome the attenuation of the 
CGRP and isoproterenol-induced responses. We did this by 
adding CGRP- and isoproterenot-induced responses. We did 
this by adding CGRP and isoproterenol,  with and without 
PDGE in a pulsatile fashion, interrupted by washing steps, 
and compared the results with those when the agents were 
added only twice over 48 h.  We also compared the effects 
of CGRP and isoproterenol with that of forskolin. Mitogene- 
sis was assessed by the incorporation of BrdU into Thy-1- 
cells in immunofluorescence assays as described in Materials 
and Methods. When viewed under an inverted phase micro- 
scope,  there was no obvious morphological difference be- 
tween cultures that were repeatedly washed in the pulsing 
regime and  those  that  were  not;  moreover,  there  was  no 
difference in  the  unstimulated  levels of cAMP in  cultures 
with and without washing (not shown). 
Fig. 6 a shows the percentage of Schwann cells that incor- 
porated BrdU into their nucleus during the last 24 h of the 
48-h experiment when the reagents were added daily without 
washing. Forskolin and PDGF both increased BrdU incorpo- 
ration about threefold,  while CGRP and isoproterenol had 
no effect. As reported by others (Davis and Stroobant, 1990; 
Weiumaster and Lemke, 1990; Chen et al.,  1991),  forskolin 
and PDGF together acted synergistically, inducing a 14-fold 
increase.  In contrast,  when the reagents were added every 
3 h, separated by 3-h wash-out periods, both CGRP and iso- 
proterenol  increased  BrdU  incorporation  about threefold, 
comparable to the effect of forskolin; moreover, CGRP and 
PDGF together were as effective as forskolin and PDGF to- 
gether (eighffold stimulation), and both combinations were 
synergistic, whereas isoproterenol and PDGF were simply 
additive (Fig.  6  b).  Whereas the combination of forskolin 
and PDGF gave a  14-fold stimulation with the unpulsed re- 
gime (Fig. 6 a), it gave only an eightfold stimulation in the 
pulsed  regime  (Fig.  6  b),  indicating  that  the  synergy  is 
greater if adenylate cyclase is continually stimulated. 
Discussion 
Schwann cells generally grow very slowly in culture, with a 
Figure  5.  Activity  of CGRP 
after incubation with Schwann 
ceils was determined by trans- 
ferring culture medium from a 
set of Schwann cells incubated 
with 10  -s M CGRP for 3 h to 
a  fresh  set of Schwann cells 
for 5 min. The levels of  cAMP 
in fresh ceils stimulated with 
the transferred  medium  (first 
bar)  was compared with  the 
levels of cAMP in fresh cells 
stimulated  with  fresh  CGRP 
(second bar) and the level of 
cAMP in the cells after 3 h of incubation with CGRP (third bar); 
in addition  fresh  CGRP was added  for 5 rain to another  set of 
Schwarm cell previously incubated with CGRP for 3 h (fourth bar). 
The controls are sets of cultures treated in the same way but without 
the addition of CGRP. 
doubling time of 8-10 d even in the presence of 10% serum 
(Raft et al.,  1978a;  Davis and Stroobant,  1990).  Similarly, 
low levels of DNA synthesis are seen in Schwarm cells grown 
in defined media, with only a small percentage of cells incor- 
porating BrdU during a 24-h pulse in this study and that of 
Stewart  et  al.  (1991).  The  mitogens  PDGF-BB,  FGF-1, 
FGF-2,  and  TGF-/~  have little  effect on  call  proliferation 
when added either with serum (Ridley et al.,  1989;  Davis 
and Stroobant,  1990;  Eccleston et al.,  1990;  Weinmaster 
and Lemke, 1990) or without (Chen et al.,  1991; Stewart et 
al.,  1991; Schubert,  1992). In the presence of 5-10 #M for- 
skolin,  however,  each  of these  mitogens  causes  Schwann 
cells to double in number in 1-2 d (Ridley et al., 1989; Davis 
and Stroobant,  1990;  Weinmaster and Lemke,  1990).  Al- 
though GGF is a mitogen without forskolin, forskolin also 
enhances the effect of GGF on Schwann  cell proliferation 
(Davis and Stroobant,  1990;  Goodearl et al.,  1993;  Mar- 
chionni et al.,  1993).  Indeed, a  common way of obtaining 
large numbers of Schwann cells for biochemical studies is to 
"expand" the cultures with either GGF or PDGF-BB in the 
presence of forskolin. In this article, we show that 1/~M of 
forskolin increases the incorporation of BrdU into DNA in 
Figure 6.  Schwarm cells were plated at high density and grown in 
defined medium for 3 d. (a) Drugs were added on the second and 
third day for a total of 48 h.  (b) Drugs were added every 6 h for 
3 h starting on the second day and continuing for a total of 37 h; 
3 h after each addition of drugs, wells were carefully washed with 
2 x  1 ml of medium and left to incubate before adding fresh drugs 
3 h later. For the final 11 h of incubation, the drugs were left in con- 
tinuously. BrdU was added for the last 24 h of incubation for both 
a and b. Concentrations of drugs were as follows: 1 mM forskolin; 
10  -s M CGRP;  10  -6 M isoproterenol;  10 ng/ml PDGF-BB. The 
number of Schwann cells that had synthesized DNA in the last 24 h 
of culture was determined by counting the number of BrdU  + cells 
in random fields as a percentage of the total Schwann cells; at least 
300 cells were counted on each coverslip. 
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in at least 10 different experiments), an increase that would 
decrease the doubling time from 10 to ,,o2 d. Thus significant 
proliferation of Schwann cells in culture in the presence of 
PDGF seems only to occur if  the cells are treated at the same 
time with agents that raise intracellular cAMP levels. 
Which  of  the  potential  ligands  that  might  increase 
Schwann cell cAMP levels are present in the nerve and which 
might be available after nerve injury? Norepinephrine, the 
agonist for the B-adrenergic receptor, accumulates for 2 d af- 
ter a nerve crush, but enzymes that synthesize this transmit- 
ter decrease in injured nerve (Cheah and Geffen, 1973). The 
neuropeptides VIE PHI, and CGRP are all known to stimu- 
late adenylate cyclase in many cell types, They are made and 
transported along peripheral axons and accumulate at the 
site of nerve injury (Lundberg et al., 1981; Kashihara et al., 
1989).  Interestingly, although CGRP  in  sensory neurons 
decreases after injury, it increases in motor neurons and con- 
tinues to accumulate at the leading edge of regrowing axons. 
Both VIP and PHI, which are encoded by the same mRNA, 
are present in sympathetic neurons and a few sensory neu- 
rons; after injury, the majority of sensory neurons now ex- 
press both VIP and PHI (for a  review see Hokfelt et al., 
1994). Thus CGRE VIP, PHI, and norepinephrine are possi- 
ble candidates for signals that increase Schwann cell cAMP. 
VIP and ~-adrenergic agonists were shown previously to in- 
crease cAMP levels in cultured Schwann cells when added 
at high doses (Yasuda et al., 1988), but when they and CGRP 
were tested in a 48-h mitogen assay with PDGF (Davis and 
Stroobant, 1990) or GGF (Stewart et al., 1991), they could 
not mimic the effects of forskolin. 
In this article, we show that CGRP and isoproterenol in- 
crease intraceUular cAMP in cultured Schwann cells. The 
magnitude of the response of Schwann cells to CGRP (8-10- 
fold in 5 min with 5  x  10  -8 M  CGRP without IBMX) is 
among the largest reported for any cell type. VIP also in- 
creased cAMP in some experiments but the effect was small. 
The response of Schwann cells to both CGRP or isoprotere- 
nol rapidly desensitized, even in the presence of the phos- 
phodiesterase inhibitor IBMX, suggesting that CGRP recep- 
tors desensitize in similar fashion to the well-documented 
desensitization of ~-adrenergic receptors. 
We thought it likely that attenuation of  the cAMP response 
when CGRP and isoproterenol were added continuously for 
48  h  could explain the  lack of effect of these agents on 
Schwann cell proliferation reported by Davis and Stroobant 
(1990) and Stewart et al. (1991). We therefore added them 
in pulsatile fashion with periods without agents to  allow 
recovery from desensitization. We also used 10  -8 M CGRP 
because we found that desensitization was reduced with this 
dose and compensated  for the below-maximal initial re- 
sponse. In this way we were able to show that both CGRP 
and isoproterenol substantially increased the number of cells 
synthesizing DNA in 24 h from 10 to ,o25 % in the presence 
of PDGF,  which  would  give  a  doubling time  of "~4  d. 
Moreover, both CGRP and isoproterenol were as effective as 
1 #M of forskolin delivered in the same fashion. 
Because the effect of forskolin on proliferation was less 
when it was given in a pulsatile fashion than when it was 
given continuously, it is clear that the time period over which 
adenylate cyclase is activated is crucial for the effectiveness 
of  this signal in potentiating the action of PDGE Weinmaster 
and  Lemke  (1990) showed that  increasing  Schwann  cell 
cAMP with forskolin led to increased synthesis of the PDGF 
/~ receptor and suggested that regulation of the number of 
mitogen receptors provides a general mechanism whereby 
cAMP potentiates the action of mitogens: only cells that re- 
spond in this fashion to forskolin show the increase in syn- 
thesis of mitogen receptor; cells that do not show potentia- 
tion with forskolin do not increase  synthesis of mitogen 
receptors.  In their study, Weinmaster and Lemke (1990) 
showed that the ceils required 12-24 h of forskolin treatment 
to increase the amount of PDGF/3 receptor mRNA; a single 
3-h pulse of forskolin was ineffective. As discussed by Wein- 
master and Lemke (1990),  other permissive effects of the 
cAMP signal are not excluded, but it is interesting that the 
erbB2 receptor is also upregulated in Schwann cells by for- 
skolin, although it is not clear if this or a related receptor 
is the real receptor for GGF on Schwann ceils (for a review 
see Mudge, 1993). 
CGRP is a very good substrate for the neutral endopep- 
tidase 24.11 (Davies et al.,  1992;  Turner, A. J., personal 
communication).  Both  myelinating  and  nonmyelinating 
Schwann ceUs express endopeptidase 24.11 on their surface 
during  development and  postnatally,  although  it  is  sup- 
pressed in adult myelinating Schwann cells (Kioussi et al., 
1992).  Moreover,  endopeptidase 24.11  is upregulated on 
both Schwann cells and endoneurial fibroblasts after injury 
to peripheral nerves (Kenny and Bourne, 1991). It is likely, 
therefore, that the activity of released CGRP could be termi- 
nated in much the same way that the action of acetylcholine 
is terminated by acetylcholinesterase at the neuromuscular 
junction, thus preventing desensitization of the receptors. 
Our attempts to minimize desensitization of Schwann cells 
in culture by washing out the drugs and allowing time for 
recovery was necessarily crude because of the limits im- 
posed by changing the culture medium every few hours; 
more frequent changes were impractical. If endogenous en- 
dopeptidase 24.11 efficiently degrades CGRP in the small 
extracellular space within the endoneurium, prevention of 
desensitization in vivo would be much more effective than 
was the pulsatile treatment in our culture experiments. It is 
unclear whether inactivation and/or reuptake of norepineph- 
rine occurs at the site of nerve injury. It seems likely that 
neuropeptides and norepinephrine are released from the tips 
of regenerating axons for the following reasons: (a) axons are 
electrically active during regeneration, and (b) large dense- 
cored vesicles, which contain these molecules, can release 
their contents at nonsynaptic sites (Zhu et al.,  1986). 
The immunopanning method described here, using anti- 
Thy-1 antibodies to deplete fibroblasts from the dissociated 
sciatic nerve cell suspension, offers several advantages over 
previously described methods, such as complement-medi- 
ated cell lysis and/or pulsing with mitotic inhibitors such as 
cytosine arabinoside, which are used frequently to enrich for 
Schwann cells (Raft et al., 1978a; Ridiey et al., 1989; Davis 
and Stroobant,  1990;  Eccleston et al.,  1990;  Weinmaster 
and Lemke,  1990;  Stewart et al.,  1991; Schubert,  1992; 
Goodearl et al.,  1993):  cells are ready to plate for experi- 
ments on the same day as dissociation, the yield from the ini- 
tial cell suspension is high so that "expansion" in mitogen and 
forskolin is not necessary, and the purity is >97 %. Growing 
the  Schwann cells  in  defined medium without serum  in- 
creases  the  purity  to  >99%  because  the  contaminating 
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of  plating, die within 2 d in culture. The Schwann cells, how- 
ever, survive for >1 mo in the defined medium on laminin 
provided they are plated at high density. We found that plat- 
ing the Schwann cells at high density also increased their 
adhesion to the coverslips, allowing extensive washing dur- 
ing the division experiments. 
Our results with PDGF and forskolin are different from 
some other studies, even when the drugs were added con- 
tinuously. We attribute this difference to our different plating 
procedure. We saw  substantial DNA synthesis in response 
to PDGF and  1 #M  of forskolin when the cells were in 
serum-free defined medium: 40-60% of the Schwann cells 
incorporated BrdU in 24 h in contrast to the study by Stewart 
et al.  (1991),  in which only 6%  of the cells incorporated 
BrdU in 24 h when exposed to PDGF and 10 #M of forskolin 
(there was  no DNA  synthesis in  1 /zM  and PDGF).  Our 
results  with  forskolin and  PDGF  added  continuously  in 
defined medium are, however, similar to those reported for 
Schwann cells grown in serum (Chen et al., 1991; Davis and 
Stroobant, 1990; Weinmaster and Lemke, 1990). The rele- 
vant differences in culture methods could be that our cells 
were never exposed to forskolin, serum, or cytosine arabino- 
side before the experiment, and they were plated at high den- 
sity on  laminin.  In  addition,  we  found that high-density 
Schwann cells survive indefinitely in serum-free medium at 
this density, whereas lower density cultures die at ~10 d. 
Perhaps as a consequence of being healthier at high density, 
the magnitude of the increase in cAMP in response to CGRP 
was greater when compared with plating the same number 
of cells over a larger surface area. In the study by Yasuda et 
al. (1988) with VIP and isoproterenol, increases in cAMP re- 
quired the presence of IBMX and concentrations of both 
drugs >10  -~ M; moreover, these effects did not plateau even 
at 10  -4 M. In contrast, in our experiments, the effects with 
CGRP and isoproterenol on Schwann cells saturated at 5  x 
10  -s M  and  10  --6, respectively. 
Fibroblasts also responded to CGRP and isoproterenol, as 
well as to both VIP and PHI, particularly in the older fibro- 
blast cultures; the fibroblast response to CGRP was termi- 
nated more rapidly than was the Schwann cell response to 
CGRP, even in the presence of IBMX,  suggesting that the 
CGRP receptors in the two cells types desensitize to CGRP 
at different rates. In contrast to the effects on proliferation 
of  Schwann  cells,  forskolin  inhibits  the  proliferation  of 
sciatic nerve fibroblasts induced by PDGF (Kahn, M., and 
A.W.  Mudge,  unpublished  results),  which  might  favor 
regeneration by preventing formation of a fibroblast scar. Be- 
cause sciatic nerve fibroblasts express endopeptidase 24.11 
on their surface, a  role for CGRP in regulating fibroblast 
cAMP-dependent effects is also possible. Both CGRP and 
VIP are also known to increase cAMP levels in macrophages 
(Wiik, 1989; Vignery et al.,  1991) and we have also shown 
that these peptides increase cAMP in macrophages isolated 
from injured peripheral  nerves (Bindemann,  N.  W.,  and 
A. W.  Mudge,  unpublished  results);  increasing  levels  of 
cAMP in macrophages is known to inhibit macrophage acti- 
vation (Nong et al.,  1989; Ohmori et al.,  1990), and it may 
be important to inactivate macrophages as the axons regen- 
erate. 
In summary, our studies suggest that CGRP may be an en- 
dogenous ligand that activates Schwann cell adenylate cy- 
clase and potentiates the mitogenic action of PDGF. Sciatic 
nerve fibroblasts and macrophages also increase their levels 
of cAMP after exposure to both CGRP and VIP, so that a 
number of cAMP-dependent nonneural cell functions such 
as fibroblast proliferation and macrophage activation may be 
regulated during nerve regeneration by the release of these 
neuropeptides as the nerve advances. Neuronal CGRP and 
VIP, which are upregulated after injury and uniquely activate 
adenylate cyclase, l~aay thus serve as heralds of the axons ap- 
proaching the uninnervated normeural cell territory eliciting 
an orchestrated cellular response conducive to nerve regen- 
eration. 
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